Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Pethe

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Expert Opinion on Drug Discovery|June 19, 2023
Novel targets and inhibitors of the <i>Mycobacterium tuberculosis</i> cytochrome <i>bd</i> oxidase to foster anti-tuberculosis drug discoveryAmaravadhi Harikishore, Vikneswaran Mathiyazakan, Kevin Pethe, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Turbidity-Based MIC Assay and Characterization of Spontaneous Drug Resistant Mutants in Mycobacterium ulceransSangeeta Susan Thomas, Nitin Pal Kalia, Kevin Pethe
Archives of Pharmacal Research|August 12, 2015
Next-generation antimicrobials: from chemical biology to first-in-class drugsMichelle Lay Teng Ang, Paul Murima, Kevin Pethe
Antimicrobial Agents and Chemotherapy|September 20, 2021
The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessusRia Sorayah, Garret C Moraski, Daniel Barkan, et al.
ACS Infectious Diseases|May 8, 2020
Features and Functional Importance of Key Residues of the <i>Mycobacterium tuberculosis</i> Cytochrome <i>bd</i> OxidaseEkaterina Sviriaeva, Malathy Sony Subramanian Manimekalai, Gerhard Grüber, et al.
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagySylvie Alonso, Kevin Pethe, David G Russell, et al.
Microbiology (Reading, England)|October 3, 2009
Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viabilityMartin Gengenbacher, Srinivasa P S Rao, Kevin Pethe, et al.
Emerging Infectious Diseases|February 24, 2022
Sensitivity of Mycobacterium leprae to TelacebecRamanuj Lahiri, Linda B Adams, Sangeeta Susan Thomas, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2023
Cryo-Electron Microscopy Structure of the <i>Mycobacterium tuberculosi</i>s Cytochrome <i>bcc</i>:<i>aa</i><sub>3</sub> Supercomplex and a Novel Inhibitor Targeting Subunit Cytochrome <i>c</i>IVikneswaran Mathiyazakan, Chui-Fann Wong, Amaravadhi Harikishore, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Expert Opinion on Drug Discovery|June 19, 2023
Novel targets and inhibitors of the <i>Mycobacterium tuberculosis</i> cytochrome <i>bd</i> oxidase to foster anti-tuberculosis drug discoveryAmaravadhi Harikishore, Vikneswaran Mathiyazakan, Kevin Pethe, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Turbidity-Based MIC Assay and Characterization of Spontaneous Drug Resistant Mutants in Mycobacterium ulceransSangeeta Susan Thomas, Nitin Pal Kalia, Kevin Pethe
Archives of Pharmacal Research|August 12, 2015
Next-generation antimicrobials: from chemical biology to first-in-class drugsMichelle Lay Teng Ang, Paul Murima, Kevin Pethe
Antimicrobial Agents and Chemotherapy|September 20, 2021
The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessusRia Sorayah, Garret C Moraski, Daniel Barkan, et al.
ACS Infectious Diseases|May 8, 2020
Features and Functional Importance of Key Residues of the <i>Mycobacterium tuberculosis</i> Cytochrome <i>bd</i> OxidaseEkaterina Sviriaeva, Malathy Sony Subramanian Manimekalai, Gerhard Grüber, et al.
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagySylvie Alonso, Kevin Pethe, David G Russell, et al.
Microbiology (Reading, England)|October 3, 2009
Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viabilityMartin Gengenbacher, Srinivasa P S Rao, Kevin Pethe, et al.
Emerging Infectious Diseases|February 24, 2022
Sensitivity of Mycobacterium leprae to TelacebecRamanuj Lahiri, Linda B Adams, Sangeeta Susan Thomas, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2023
Cryo-Electron Microscopy Structure of the <i>Mycobacterium tuberculosi</i>s Cytochrome <i>bcc</i>:<i>aa</i><sub>3</sub> Supercomplex and a Novel Inhibitor Targeting Subunit Cytochrome <i>c</i>IVikneswaran Mathiyazakan, Chui-Fann Wong, Amaravadhi Harikishore, et al.
Pageof 12